Cogent Biosciences Highlights Additional Data with Six Bezuclastinib Posters from SUMMIT Trial at 2026 AAAAI Annual Meeting
February 28, 2026 09:45 ET | Source: Cogent Biosciences, Inc. Bezuclastinib mean…
Cogent Biosciences Announces Participation in the Citi Biopharma Conference
August 26, 2025 08:00 ET | Source: Cogent Biosciences, Inc. WALTHAM, Mass.…
Cogent Biosciences Announces Pricing of Upsized Public Offering of Shares of Common Stock
July 08, 2025 21:36 ET | Source: Cogent Biosciences, Inc. WALTHAM, Mass.…
